Creo Medical (1RC) AI Stock Analysis

2 Followers

Creo Medical

(Stuttgart:1RC)

Rating:―N/A

Action:N/A

Date:―

No summary available

Positive Factors

Manageable leverageRelatively low debt compared with equity gives Creo financial flexibility while it scales its medical-device business. This can help preserve capacity for commercial investment and product development, although the benefit depends on containing ongoing losses and cash use.

Negative Factors

Persistent operating lossesLarge recurring operating losses show that the current revenue base remains well below the scale needed to support Creo’s cost structure. Until core operations approach breakeven, growth may not translate into durable earnings and financial risk will remain elevated.

Creo Medical (1RC) vs. iShares MSCI Germany ETF (EWG)

Market Cap: EUR 48.84M
Dividend Yield: ―
Average Volume (3M): ―
Price to Earnings (P/E): -2.3
Beta (1Y): 1.07
Revenue Growth: ―
EPS Growth: ―
Country: Germany
Employees: 104
Sector: Healthcare
Sector Strength: 51
Industry: Medical - Devices

Creo Medical Business Overview & Revenue Model

Company Description

Creo Medical Limited, a UK-based enterprise and subsidiary of Creo Medical Group plc, specializes in the innovation and creation of electrosurgical medical devices for surgical endoscopy applications. Founded in 2003 as MicroOncology Ltd and headquar...

Creo Medical Peers Comparison

Overall Rating

UnderperformOutperform

Sector (51)

Financial Indicators

DE:1RC against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
GB:TSTL	80Outperform	GBP 188.69M	23.23	23.05%	3.66%	10.02%	19.83%
GB:SN	72Outperform	GBP 9.90B	20.39	12.25%	2.53%	2.17%	27.33%
GB:AMS	60Neutral	GBP 612.42M	166.47	1.44%	1.66%	6.05%	-60.00%
Sector *	51Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
GB:SUN	49Neutral	GBP 3.03M	-3.25	-15.47%	―	-3.68%	20.00%

* Healthcare Sector Average

Performance Comparison

DE:1RC and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
DE:1RC	Creo Medical	0.12	-0.00	-1.60%
GB:AMS	Advanced Medical Solutions	283.00	72.45	34.41%
GB:SUN	Surgical Innovations Group Plc	0.33	-0.25	-43.97%
GB:TSTL	Tristel plc	387.50	31.55	8.86%
GB:SN	Smith & Nephew (UK)	1161.00	-76.66	-6.19%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Creo Medical AI Stock Analysis